TY - JOUR TI - The BET family in immunity and disease AU - Wang, Nian AU - Wu, Runliu AU - Tang, Daolin AU - Kang, Rui T2 - Signal Transduction and Targeted Therapy AB - Innate immunity serves as the rapid and first-line defense against invading pathogens, and this process can be regulated at various levels, including epigenetic mechanisms. The bromodomain and extraterminal domain (BET) family of proteins consists of four conserved mammalian members (BRD2, BRD3, BRD4, and BRDT) that regulate the expression of many immunity-associated genes and pathways. In particular, in response to infection and sterile inflammation, abnormally expressed or dysfunctional BETs are involved in the activation of pattern recognition receptor (e.g., TLR, NLR, and CGAS) pathways, thereby linking chromatin machinery to innate immunity under disease or pathological conditions. Mechanistically, the BET family controls the transcription of a wide range of proinflammatory and immunoregulatory genes by recognizing acetylated histones (mainly H3 and H4) and recruiting transcription factors (e.g., RELA) and transcription elongation complex (e.g., P-TEFb) to the chromatin, thereby promoting the phosphorylation of RNA polymerase II and subsequent transcription initiation and elongation. This review covers the accumulating data about the roles of the BET family in innate immunity, and discusses the attractive prospect of manipulating the BET family as a new treatment for disease. DA - 2021/01/19/ PY - 2021 DO - 10.1038/s41392-020-00384-4 DP - www.nature.com VL - 6 IS - 1 SP - 1 EP - 22 LA - en SN - 2059-3635 UR - https://www.nature.com/articles/s41392-020-00384-4 Y2 - 2021/01/19/17:09:06 ER -